Nicolas Talarek

Isolation of drugs active against mammalian prions using a yeast-based screening assay

Stéphane Bach, Nicolas Talarek, Thibault Andrieu et al. · Nature Biotechnology · 2003 · 175 citations · Full text

Biochemistry, Medicine, Natural Sciences +8

Initiation of the TORC1-Regulated G0 Program Requires Igo1/2, which License Specific mRNAs to Evade Degradation via the 5′-3′ mRNA Decay Pathway

Nicolas Talarek, Elisabetta Cameroni, Malika Jaquenoud et al. · Molecular Cell · 2010 · 113 citations · Full text

Transcriptional Regulation, Natural Sciences, Rna Biology +9

A Non-Q/N-Rich Prion Domain of a Foreign Prion, [Het-s], Can Propagate as a Prion in Yeast

Vibha Taneja, Marie‐Lise Maddelein, Nicolas Talarek et al. · Molecular Cell · 2007 · 90 citations · Full text

Genetics, Molecular Biology, Non-q/n-rich Prion Domain +6

Yeast Endosulfines Control Entry into Quiescence and Chronological Life Span by Inhibiting Protein Phosphatase 2A

Séverine Bontron, Malika Jaquenoud, Stefania Vaga et al. · Cell Reports · 2012 · 90 citations · Full text

Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs

Déborah Tribouillard‐Tanvier, Suzana Dos Reis, Fabienne Gug et al. · PLoS ONE · 2008 · 63 citations · Full text